Lupus Accelerating Breakthroughs Consortium: Leveraging Collaborative Frameworks to Advance Development of Immune Resetting Therapies
3:00 pm - Thursday 3rd December 2026
- Highlighting the structure and role of the Lupus ABC public-private partnership in connecting stakeholders to accelerate lupus drug development
- Showcasing insights from CAR-T cell working group activities and early outputs from the Immune Reset working group
- Developing dashboards, consensus definitions, and standardized molecular phenotyping approaches to accelerate clinical development of potentially immune resetting therapies in lupus
